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Avian hepatitis E virus (HEV) has been identiﬁ  ed  in 
chickens; however, only 4 complete or near-complete ge-
nomic sequences have been reported. We found that the 
near-complete genomic sequence of avian HEV in chickens 
from China shared the highest identity (98.3%) with avian 
HEV from Europe and belonged to avian HEV genotype 3.
H
epatitis E virus (HEV) is a nonenveloped, positive-
sense, single-stranded RNA virus. It has 3 open read-
ing frames (ORFs) and a genome size of 7.2 kb (1). So 
far, HEV strains are classiﬁ  ed into 4 major genotypes, and 
genotypes 3 and 4 are probably zoonotic.
Avian HEVs have been identiﬁ  ed from chickens with 
big liver syndrome and hepatitis–splenomegaly syndrome. 
Each syndrome mainly causes increased deaths, reduced 
egg production, and enlarged liver and spleen (2); hepa-
titis–splenomegaly syndrome also causes accumulation of 
bloody ﬂ  uid in the abdomen and vasculitis and amyloidosis 
in the liver (3,4). Molecular epidemiologic investigations 
have shown that avian HEV infection in chickens is en-
demic to the United States and Spain (5,6). Because propa-
gating avian HEV in cell culture or embryonated eggs is 
difﬁ  cult (2,3), avian HEV is primarily detected by reverse 
transcription–PCR (RT-PCR). However, only 4 complete 
or near-complete genomic sequences have been reported to 
GenBank (7–9). We identiﬁ  ed and analyzed the near-com-
plete genomic sequence of avian HEV in a chicken ﬂ  ock 
from the People’s Republic of China.
The Study
In May 2009, hepatitis–splenomegaly syndrome af-
fected a ﬂ  ock of 37-week-old broiler breeder hens in Shan-
dong, China. This ﬂ  ock had a history of decreased egg 
production. Affected chickens had regressive ovaries, ex-
tensive necrosis and hemorrhage of the liver, and enlarged 
liver and spleen. Antibodies against avian HEV ORF2 were 
detected in 80 of 94 serum samples from the same chicken 
ﬂ  ock, according to ELISA (5,10) with the truncated ORF2 
protein used by Guo et al (10) and chicken serum diluted 
1:100 in 0.5% Tween-20 phosphate-buffered saline con-
taining 2.5% nonfat dry milk and 10% Escherichia coli 
lysate. On the basis of previous results, we used a cutoff 
optical density of 0.43 (11). Using a published method 
(12), we detected an avian HEV ORF2 RNA gene with 242 
bp in 7 of 10 fecal and 5 of 8 bile samples.
From the bile samples that were positive for the avian 
HEV ORF2 gene, we used nested RT-PCR with 5 over-
lapping fragments to amplify the near-complete genomic 
sequence of avian HEV. Primers were designed on the ba-
sis of the other 4 avian HEV near-complete sequences in 
GenBank (Table 1). The RT-PCR conditions and reaction 
mixture were designed according to the SuperScript II One-
Step RT-PCR System instructions (Invitrogen, Carlsbad, 
CA, USA). To identify the extreme 3′ genomic sequence, 
we used a modiﬁ  ed RACE (3′ rapid ampliﬁ  cation of cDNA 
ends) technique. The sense primer F5 (Table 1) was chosen 
from the ORF2 region, and the antisense primers included 
a commercially available anchored adaptor primer and an 
ampliﬁ  cation primer (Invitrogen). Using inner PCR prim-
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Table 1. Primers used for PCR amplification of the China avian 
hepatitis E virus genome 
Primer* Sequence,  5ƍ o 3ƍ† Position,  nt‡
F1-1 CCATGCCAGGGTAAGAATG  9–27 
R1-1 AAAACAGCAAGGACCTCC  1872–1889 
F1-2 CCAGGGTAAGAATGGACG  14–31 
R1-2 TAATCCAGGTGGCGAGC  1308–1324 
F2-1 CACTGTGGGTAACATTGTGGC  1071–1091 
R2-1 GTTCGACTGCTTAGCCACCTG  2935–2955 
F2-2 AGGCGGAACACGCACAGCA  1214–1232 
R2-2 TCGTCCACAATGACCCTGC  2624–2642 
F3-1 GGCTGTGTGGCATGTTCCA  1985–2003 
R3-1 GGTAAAGAGCCACCATCCAAT  4010–4030 
F3-2 CCGTGATGGTGACTTGTTGGTTGT  2262–2285 
R3-2 GGCACATCTCCGCATACTC  3586–3604 
F4-1 CCCTTCAACATTGGAGTATGC  3573–3593 
R4-1 ATCTGGTACCGTGCGAGT  4899–4916 
F4-2 ACATTGGAGTATGCGGAGATG  3580–3600 
R4-2 TTGAGCGCTCCACTGGGCT  4820–4838 
F5 GACAATTCAGCCCAGTGGA  G  4809–4828 
AUAP§ GACTCGAGTCGACATCG  A  Nonviral 
AP§ GACTCGAGTCGACATCGA  (T)17 Nonviral 
*Primers F1-1 to R1-2, F2-1 to R2-2, F3-1 to R3-2, and F4-1 to R4-2 were 
used to amplify the first, second, third, and fourth fragment of the near-
complete avian hepatitis E virus (HEV) genome. Primers F5, amplification 
primer (AUAP), and adapter primer (AP) were used to amplify the extreme 
3ƍ genomic sequence. Primers R1-1, R2-1, R3-1, R4-1, and AP are also 
reverse transcription primers. 
†Sequences of primers were designed according to the sequences of 4 
other known avian HEV strains. 
‡Positions of primers located in the complete genome are shown 
according to the Europe avian HEV isolate. 
§Commercial primer (Invitrogen, Carlsbad, CA, USA) of nonviral origin.  ers, we sequenced the PCR products of 5 fragments in both 
directions (Table 1); the sequence data were collected by an 
ABI3730 Genetic Analyzer (JinSiTe Biotech Co., Nanjing, 
China).
We assembled the near-complete genome of avian 
HEV, which was 6,660 nt long including the 3′ poly A tail, 
by using 5 overlapping fragments sequences and Laser-
gene 7.0 EditSeq computer programs (DNAStar, Madison, 
WI, USA) and designated it China avian HEV (CaHEV). 
CaHEV contained a complete ORF1 gene encoding a 
nonstructural protein of 1,522 aa, an ORF2 gene encod-
ing a capsid protein of 606 aa, an ORF3 gene encoding a 
cytoskeleton-associated phosphoprotein of 87 aa, and a 3′ 
noncoding region of 121 nt. The sequences of CaHEV were 
deposited into GenBank under accession no. GU954430.
The near-complete genomic and different region se-
quence analyses performed by using ClustalW (www.
clustal.org) and Lasergene 7.0 MegAlign software indi-
cated that CaHEV shared the highest identity (98.3%) with 
European avian HEV isolate (EaHEV) and 82.0%–82.6% 
with 3 other avian HEV isolates (Table 2). Moreover, 
compared with the different regions of 4 other avian HEV 
strains, the ORF1 gene of CaHEV shared 80.7%–98.3% nt 
and 92.7%–98.8% aa sequence identities, the ORF2 gene 
shared 84.1%–98.5% nt and 98.3%–99.7% aa sequence 
identities, the ORF3 gene shared 93.9%–98.9% nt and 
88.6%– 97.7% aa identities, and the 3′ noncoding region 
shared 78.9%–97.6% nt identities (Table 2).
ORF1 of CaHEV contained most mutations compared 
with prototype avian HEV (prototype aHEV); 5, 16, and 29 
nonsilent mutations occurred in the methyltransferase, heli-
case, and RNA-dependent RNA polymerase (RdRp) func-
tional domains, respectively (data not shown). However, 
only 2 mutations occurred in motif VII of RdRp domain 
(Figure 1, panel A), which contains 8 motifs responsible for 
virus replication (13). The 2 mutations in motif VII of the 
CaHEV RdRp domain are L(1432)M and I(1434)V. Aus-
tralian avian HEV isolate (AaHEV) also has the mutation 
in the latter position and was a transition from I(1433) to T 
(Figure 1, panel A). This position is well conserved among 
mammalian HEV isolates by the presence of V, which is 
the same as CaHEV (Figure 1, panel A).
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Table 2. Percentage identities among avian HEV strains in nucleotide/amino acid sequences* 
Sequence and strain  “Avirulent aHEV”  Prototype aHEV  AaHEV EaHEV CaHEV 
Near-complete genome sequence 
 “Avirulent  aHEV”  90.1 82.7 82.9 82.6
 Prototype  aHEV  82.5 82.2 82.0
 AaHEV  82.5 82.4
 EaHEV  98.3
CaHEV 
ORF1 
 “Avirulent  aHEV”  89.6 82.1 81.8 81.7
 Prototype  aHEV  97.4 81.6 81.0 80.7
 AaHEV  93.9 93.7 81.7 81.6
 EaHEV  92.9 93.0 93.1 98.3
 CaHEV  92.7 92.8 93.0 98.8
ORF2 
 “Avirulent  aHEV”  90.7 84.5 84.0 84.1
 Prototype  aHEV  99.0 84.3 84.4 84.5
 AaHEV  98.5 98.8 84.1 84.4
 EaHEV  98.2 98.7 98.8 98.5
 CaHEV  98.3 99.0 98.8 99.7
ORF3 
 “Avirulent  aHEV”  97.0 95.4 93.6 93.9
 Prototype  aHEV  99.0 95.4 93.6 93.9
 AaHEV  94.3 96.6 93.5 93.9
 EaHEV  88.6 88.6 92.0 98.9
 CaHEV  88.6 88.6 92.0 97.7
3cNCR
 “Avirulent  aHEV”  92.8 82.8 88.6 89.4
 Prototype  aHEV  83.6 85.5 86.3
 AaHEV  80.5 78.9
 EaHEV  97.6
CaHEV 
*HEV, hepatitis E virus; ORF, open reading frame; NCR, noncoding region. Boldface indicates percentage identities of amino acid sequences. “Avirulent 
aHEV” and prototype aHEV are avian HEV isolates from the United States, GenBank accession nos. EF206691 and AM535004, respectively. AaHEV, 
EaHEV, and CaHEV are avian HEV isolates from Australia, Europe, and China, GenBank accession nos. AM943647, AM943646, and GU954430,
respectively.  Avian Hepatitis E Virus from Chickens, China
In the ORF2 region, 6 nonsilent mutations (C4R, R5G, 
G27S, T42A, T303V, and Q473M) were determined for 
CaHEV and compared with prototype aHEV. One muta-
tion of Q(473)M, in the antigenic domain II, was seen in 
EaHEV and in CaHEV (Figure 1, panel B). Because this 
domain is unique to avian HEV, as predicted by Haqsh-
enas et al. (14) and Guo et al. (10), this point mutation 
may change the antigenicity of the epitopes in domain II 
of the capsid protein. In antigenic domain IV, a mutation of 
R(600)K occurred in the “avirulent aHEV” compared with 
other 4 avian HEV strains, including CaHEV, from the sick 
chickens (Figure 1, panel C). This mutation may affect the 
virulence of avian HEV as speculated by Billam et al. (8) 
and Billic et al. (9). The 3 putative N-linked glycosylation 
sites (255NLS [1], 510NST [2], and 522NGS [3]) are shared 
between prototype aHEV and CaHEV (data not shown). 
However, the second site is 510NNT in “avirulent aHEV” 
and AaHEV strains and is eliminated in the EaHEV strain 
(9). In human and swine HEV strains, these sites are 137NLS 
(1), 310NLT (2), and 562NLS (3). Recently, the potential N-
linked glycosylation in ORF2 was shown to prevent forma-
tion of infectious particles, but its role in other functions 
of HEV, e.g., virus virulence and cell tropism, remain to 
be elucidated (15). In the ORF3 gene, including only 83 
aa, 10 nonsilent mutations were found compared with the 
prototype aHEV, and 9 mutations were the same as EaHEV 
(data not shown).
Phylogenetic trees of the near full-length sequence of 
avian and mammalian HEV strains were constructed by us-
ing the neighbor-joining distance method and Lasergene 
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Figure 1. Amino acid sequence comparison of motif VII in the open reading frame (ORF) 1 RNA-dependent RNA polymerase (RdRp) 
region of avian, human, and swine hepatitis E viruses (HEVs) (A), antigenic domain II (B), and antigenic domain IV (C) in the ORF2 
region of avian HEV (aHEV). Residues that are conserved among aHEV isolates are shown as the consensus above the sequences; 
residues that are conserved in the HEV strains are not shown. GenBank accession numbers of human and swine HEV (sHEV) strains 
are M73218 (Burma), AF076239 (Hyderabad), D11092 (China Xingjiang), M74506 (Mexico), AF082843 (prototype sHEV), FJ527832 
(China Shanghai), AB291955 (Japan Shinagawa), AJ272108 (China T1), AB480825 (Japan HE-JF5), and FJ763142 (Korea). GenBank 
accession numbers of avian HEV strains are EF206691 (“avirulent aHEV” from the United States), AM535004 (prototype aHEV from the 
United States), AM943647 (aHEV from Australia [AaHEV]), AM943646 (aHEV from Europe [EaHEV]), and GU954430 (aHEV from China 
[CaHEV]). Boxes indicate mutations of CaHEV compared with different HEV strains.
Figure 2. Phylogenetic trees based on 
the near-complete genomic sequences 
of avian hepatitis E virus (HEV) and 10 
human and swine HEV isolates. GenBank 
accession numbers follow the name of 
HEV strains. The trees were constructed 
by the neighbor-joining method with 1,000 
bootstrap replicates using Lasergene 7.0 
(DNAStar, Madison, WI, USA). The length 
of each pair of branches represents the 
distance between sequence pairs; the units 
at the bottom of the tree indicate the number 
of substitution events.7.0 software. A bootstrap test of 1,000 replicates was used 
to evaluate the reliability of the groups. Avian HEV was 
segregated into a distinct branch separate from mammalian 
HEV; according to the genotype separation corresponding 
to their geographic origin suggested by Bilic et al. (9), Ca-
HEV belongs to avian HEV genotype 3 (Figure 2).
Conclusions
Avian HEV infection of a chicken ﬂ  ock in Shandong, 
China, was identiﬁ  ed by detection of avian HEV ORF2 an-
tibodies and viral RNA. A near-complete avian HEV ge-
nome from the ﬂ  ock was determined, and sequence analysis 
indicated that this avian HEV strain displayed the highest 
identity (98.3%) with EaHEV and belonged to avian HEV 
genotype 3.
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